• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Patient Messaging Content Associated with Initiating Hormonal Therapy after a Breast Cancer Diagnosis.与乳腺癌诊断后开始激素治疗相关的患者信息内容
AMIA Annu Symp Proc. 2020 Mar 4;2019:962-971. eCollection 2019.
2
The therapy is making me sick: how online portal communications between breast cancer patients and physicians indicate medication discontinuation.治疗让我感到不适:乳腺癌患者与医生在线门户交流如何预示停药。
J Am Med Inform Assoc. 2018 Nov 1;25(11):1444-1451. doi: 10.1093/jamia/ocy118.
3
Learning When Communications Between Healthcare Providers Indicate Hormonal Therapy Medication Discontinuation.了解医疗服务提供者之间的沟通何时表明激素治疗药物停用。
AMIA Annu Symp Proc. 2018 Dec 5;2018:1591-1600. eCollection 2018.
4
Optimizing word embeddings for small dataset: a case study on patient portal messages from breast cancer patients.优化小数据集的词向量:以乳腺癌患者的患者门户消息为例的研究。
Sci Rep. 2024 Jul 12;14(1):16117. doi: 10.1038/s41598-024-66319-z.
5
Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.早期 HER2 阳性乳腺癌患者的内分泌治疗模式:一项全国性队列研究。
Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):812-820. doi: 10.1002/pds.4751. Epub 2019 Mar 12.
6
Talking About My Care: Detecting Mentions of Hormonal Therapy Adherence Behavior in an Online Breast Cancer Community.聊聊我的护理:在一个在线乳腺癌社区中检测激素治疗依从行为的提及情况
AMIA Annu Symp Proc. 2018 Apr 16;2017:1868-1877. eCollection 2017.
7
High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I-III Breast Cancer Patients Treated in a Safety-Net Healthcare System.在安全网医疗系统接受治疗的未参保Ⅰ-Ⅲ期乳腺癌患者中辅助激素治疗的高起始率
J Womens Health (Larchmt). 2017 Jun;26(6):655-661. doi: 10.1089/jwh.2016.6099. Epub 2017 Mar 15.
8
Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy.雄激素受体表达对氟甲睾酮治疗的、对当代激素疗法耐药的雌激素受体阳性转移性乳腺癌的影响。
Breast Cancer Res Treat. 2016 Nov;160(1):101-109. doi: 10.1007/s10549-016-3986-6. Epub 2016 Sep 23.
9
Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy.肿瘤学家与患者关于乳腺癌辅助激素治疗的讨论:一项聚焦于治疗依从性和持续性的语言研究结果
J Support Oncol. 2007 Mar;5(3):139-43.
10
Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.辅助激素治疗停药后乳腺癌患者的治疗重启。
J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx041.

引用本文的文献

1
Improving Emergency Department Visit Risk Prediction: Exploring the Operational Utility of Applied Patient Portal Messages.改善急诊科就诊风险预测:探索应用患者门户网站信息的操作效用。
AMIA Annu Symp Proc. 2025 May 22;2024:610-619. eCollection 2024.
2
Optimizing word embeddings for small dataset: a case study on patient portal messages from breast cancer patients.优化小数据集的词向量:以乳腺癌患者的患者门户消息为例的研究。
Sci Rep. 2024 Jul 12;14(1):16117. doi: 10.1038/s41598-024-66319-z.
3
Optimizing Word Embeddings for Patient Portal Message Datasets with a Small Number of Samples.针对少量样本的患者门户消息数据集优化词嵌入
Res Sq. 2024 May 15:rs.3.rs-4350387. doi: 10.21203/rs.3.rs-4350387/v1.
4
The Hidden Patient Connections: Predicting Hormonal Therapy Medication Discontinuation Using Hypergraph Neural Network on Clinical Communications.隐藏的患者关联:基于临床交流使用超图神经网络预测激素治疗药物停用情况
AMIA Jt Summits Transl Sci Proc. 2023 Jun 16;2023:505-514. eCollection 2023.
5
Electronic Medical Record-Based Electronic Messaging Among Patients with Breast Cancer: A Systematic Review.基于电子病历的乳腺癌患者间电子信息交流:系统评价。
Appl Clin Inform. 2023 Jan;14(1):134-143. doi: 10.1055/a-2004-6669. Epub 2022 Dec 29.

本文引用的文献

1
Learning When Communications Between Healthcare Providers Indicate Hormonal Therapy Medication Discontinuation.了解医疗服务提供者之间的沟通何时表明激素治疗药物停用。
AMIA Annu Symp Proc. 2018 Dec 5;2018:1591-1600. eCollection 2018.
2
Factors influencing oncologists' prescribing hormonal therapy in women with breast cancer: a qualitative study in Córdoba, Argentina.影响肿瘤科医生为乳腺癌女性开具激素治疗药物处方的因素:阿根廷科尔多瓦的一项定性研究。
Int J Equity Health. 2019 Feb 18;18(1):35. doi: 10.1186/s12939-019-0936-z.
3
The therapy is making me sick: how online portal communications between breast cancer patients and physicians indicate medication discontinuation.治疗让我感到不适:乳腺癌患者与医生在线门户交流如何预示停药。
J Am Med Inform Assoc. 2018 Nov 1;25(11):1444-1451. doi: 10.1093/jamia/ocy118.
4
Talking About My Care: Detecting Mentions of Hormonal Therapy Adherence Behavior in an Online Breast Cancer Community.聊聊我的护理:在一个在线乳腺癌社区中检测激素治疗依从行为的提及情况
AMIA Annu Symp Proc. 2018 Apr 16;2017:1868-1877. eCollection 2017.
5
A patient in the clinic; a person in the world. Why shared decision making needs to center on the person rather than the medical encounter.诊所里的一位患者;世界上的一个人。为何共同决策需要以患者本人而非医疗过程为中心。
Patient Educ Couns. 2017 Mar;100(3):600-604. doi: 10.1016/j.pec.2016.10.016. Epub 2016 Oct 21.
6
Mapping the Decision-Making Process for Adjuvant Endocrine Therapy for Breast Cancer: The Role of Decisional Resolve.绘制乳腺癌辅助内分泌治疗的决策过程:决策决心的作用。
Med Decis Making. 2017 Jan;37(1):79-90. doi: 10.1177/0272989X16640488. Epub 2016 Apr 6.
7
Adherence to endocrine therapy in breast cancer adjuvant and prevention settings.乳腺癌辅助治疗和预防环境下的内分泌治疗依从性。
Cancer Prev Res (Phila). 2014 Apr;7(4):378-87. doi: 10.1158/1940-6207.CAPR-13-0389. Epub 2014 Jan 17.
8
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.雌激素受体阳性乳腺癌诊断后继续辅助他莫昔芬治疗 10 年与 5 年后停药的长期疗效:ATLAS,一项随机试验。
Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1.
9
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.二甲双胍治疗早期乳腺癌:一项新辅助治疗的前瞻性机会窗口研究。
Breast Cancer Res Treat. 2012 Oct;135(3):821-30. doi: 10.1007/s10549-012-2223-1. Epub 2012 Aug 30.
10
Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women.低收入女性患者对辅助性激素疗法的依从性及其与乳腺癌复发和生存的关系。
Am J Clin Oncol. 2013 Apr;36(2):181-7. doi: 10.1097/COC.0b013e3182436ec1.

与乳腺癌诊断后开始激素治疗相关的患者信息内容

Patient Messaging Content Associated with Initiating Hormonal Therapy after a Breast Cancer Diagnosis.

作者信息

Yin Zhijun, Warner Jeremy L, Chen Qingxia, Malin Bradley A

机构信息

Vanderbilt University, Nashville, TN.

出版信息

AMIA Annu Symp Proc. 2020 Mar 4;2019:962-971. eCollection 2019.

PMID:32308893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7153093/
Abstract

Hormonal therapy is an effective, but challenging, long-term treatment for patients with hormone-receptor-positive breast cancer. Raising the rate of patients who initiate therapy may be possible by characterizing the factors that influence a patient's decision. We hypothesized that online patient portal messages convey such factors. To investigate this hypothesis, we focused on breast cancer patients who were prescribed hormonal therapy at Vanderbilt University Medical Center and sent messages through the portal between diagnosis and therapy initiation. We first conducted a topic modeling analysis to generate the main themes of portal messages. We subsequently applied survival analysis to learn the association between the factors conveyed in messages, in term of semantic word groups, and the time elapsed from diagnosis to therapy initiation. We found that consulting with healthcare providers increased the probability of therapy initiation, while mentions of symptoms or negative emotions exhibited a reduced probability.

摘要

激素疗法是激素受体阳性乳腺癌患者的一种有效但具有挑战性的长期治疗方法。通过确定影响患者决策的因素,提高开始治疗的患者比例或许是可行的。我们推测在线患者门户消息传达了这些因素。为了验证这一推测,我们聚焦于在范德堡大学医学中心接受激素疗法处方的乳腺癌患者,并在诊断至开始治疗期间通过门户发送消息。我们首先进行了主题建模分析,以生成门户消息的主要主题。随后,我们应用生存分析来了解消息中以语义词组表示的因素与从诊断到开始治疗所经过的时间之间的关联。我们发现,与医疗服务提供者咨询会增加开始治疗的可能性,而提及症状或负面情绪则显示可能性降低。